People · Operator
Named in public records as an officer, director or promoter · active 2010–2010 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SCOLR Pharma, Inc. | — | Pharmaceuticals | Series A | $6.6M | $9.5M | 2010 |
Bruce S Morra at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Bruce S Morra on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Michael N Taglich | 1 | 8 |
| Carl J Johnson | 1 | 2 |
| Randall L-W Caudill | 1 | 2 |
| Herbert L Lucas | 1 | 1 |
| Wayne L. Pines | 1 | 1 |
| Jeffrey B Reich | 1 | 1 |
| Richard M Levy | 1 | 1 |
| Stephen J Turner | 1 | 1 |
| MaryLou W Arnett | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.